Lexeo Therapeutics (LXEO) Change in Taxes (2022 - 2023)

Lexeo Therapeutics (LXEO) reported Change in Taxes of $141000.0 for Q4 2023, little changed on a YoY basis from $141000.0 in Q4 2022, and little changed sequentially from $141000.0 in Q4 2022.

Lexeo Therapeutics (LXEO) Change in Taxes (2022 - 2023) Analysis & Trends

Lexeo Therapeutics (LXEO) has 2 years of Change in Taxes data on file, last reported at $141000.0 in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -8,939.03
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Lexeo Therapeutics 379.94 Mn 379.94 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 141,000.00
Dec 31, 2023 141,000.00
Dec 31, 2022 141,000.00
Dec 31, 2022 141,000.00